Brandon May

Brandon May is a freelance medical writer and owner of May Medical Communications, LLC. He holds a BS in Nutrition and Dietetics from the University of Houston. Throughout his career, he has written over 700 medical news articles across several different therapeutic areas. In addition to covering the medical news, Brandon also creates content for continuing medical education providers, hospitals, and pharmaceutical and medical device companies across the globe.

All articles by Brandon May

Asthma

The Effect of Monitoring Devices on Inhaler Adherence and Other Asthma Outcomes

Brandon May

September 17, 2021

A meta-analysis identified the effects of the electronic adherence monitoring devices on inhaler adherence, exacerbations, and asthma control in children.

Critical Care

Outcomes for Milrinone vs Dobutamine in Cardiogenic Shock

Brandon May

September 13, 2021

Which inotropic agent should clinicians use in patients with cardiogenic shock, milirone or dobutamine?

Critical Care

Corticosteroids May Reduce Ventilation Use, Duration in Patients With ARDS

Brandon May

September 10, 2021

A review of 18 meta-analyses of corticosteroid use in ARDS examined corticosteroids’ effect on ARDS prevention, mortality, ventilator-free days, and ICU stay.

COPD

Chronic Noninvasive Ventilation for COPD May Improve Blood Gases, HRQoL

Brandon May

September 9, 2021

A new Cochrane review of 21 published studies examined effect of chronic noninvasive ventilation for stable and post-exacerbation COPD.

COPD

Multidisciplinary COPD Screening May Improve Smoking Cessation Efforts

Brandon May

September 8, 2021

A pilot study of diverse health professionals explored the feasibility and effectiveness of screening and educating patients at high-risk for COPD.

Critical Care

Does Stopping RAS Inhibition Affect COVID-19 Course, Recovery?

Brandon May

September 1, 2021

Older patients with symptomatic SARS-CoV-2 infection and comorbidities who are chronically treated with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) may experience a faster and better recovery from COVID-19 by discontinuing use of renin–angiotensin system (RAS) inhibitors; however, stopping these therapies does not seem to affect the maximum severity of COVID-19-related illness,…

Tuberculosis

Combined Antibiotic Dry Powder Inhaler Offers Some Relief for Pulmonary TB

Brandon May

August 31, 2021

A recent trial compared the efficacy of standard oral therapy for pulmonary TB with a dry powder inhaler containing fixed doses of isoniazid, rifampicin, pyrazinamide, and levofloxacin.

coronavirus disease 2019 covid lungs illustration

Critical Care

Algorithm for Noninvasive Respiratory Support Paths in COVID-19 Management

Brandon May

August 30, 2021

A new algorithm offers guidance on when to start and stop noninvasive respiratory therapies for COVID-19.

Obstructive Sleep Apnea-OSA

AHA Releases Scientific Statement on Obstructive Sleep Apnea and Cardiovascular Health in Children and Adolescents

Brandon May

August 27, 2021

The American Heart Association (AHA) released a scientific statement summarizing the effects of obstructive sleep apnea on the cardiovascular health of children and adolescents, as well as the current best practices for diagnosis and evaluation of CVD-related complications of OSA.

General Pulmonology

Study Finds No Link Between BNT162b2 COVID-19 Vaccine and Facial Nerve Palsy

Brandon May

August 27, 2021

Study investigators assessed whether the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine is associated with greater risk of peripheral facial nerve palsy.

Next post in General Pulmonology